Terms: = Endocrine gland cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Staging
11 results:
1. Development of a radiomic-clinical nomogram for prediction of survival in patients with serous ovarian cancer.
Hong Y; Liu Z; Lin D; Peng J; Yuan Q; Zeng Y; Wang X; Luo C
Clin Radiol; 2022 May; 77(5):352-359. PubMed ID: 35264303
[TBL] [Abstract] [Full Text] [Related]
2. Magnetic Resonance Imaging Radiomics-Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Multicenter Study.
Shi Z; Ma C; Huang X; Cao D
J Magn Reson Imaging; 2022 Mar; 55(3):823-839. PubMed ID: 34997795
[TBL] [Abstract] [Full Text] [Related]
3. Original study: The rescue staging for pancreatic ductal adenocarcinoma with inadequate examined lymph nodes.
Fu N; Wang W; Cheng D; Wang J; Xu Z; Deng X; Peng C; Chen H; Shen B
Pancreatology; 2021 Jun; 21(4):724-730. PubMed ID: 33642141
[TBL] [Abstract] [Full Text] [Related]
4. Association Between Programmed Death-Ligand 1 Expression and Clinicopathological Characteristics, Structural Recurrence, and Biochemical Recurrence/Persistent Disease in Medullary Thyroid Carcinoma.
Shi X; Yu PC; Lei BW; Li CW; Zhang Y; Tan LC; Shi RL; Wang J; Ma B; Xu WB; Wang X; Hu JQ; Huang NS; Wei WJ; Wang Y; Chen TZ; Wang YL; Ji QH
Thyroid; 2019 Sep; 29(9):1269-1278. PubMed ID: 31328653
[No Abstract] [Full Text] [Related]
5. Is adjuvant chemotherapy beneficial for patients with FIGO stage IC adult granulosa cell tumor of the ovary?
Wang D; Xiang Y; Wu M; Shen K; Yang J; Huang H; Ren T
J Ovarian Res; 2018 Mar; 11(1):25. PubMed ID: 29587835
[TBL] [Abstract] [Full Text] [Related]
6. Development and Validation of a Nomogram for Predicting Survival in Patients with Advanced Pancreatic Ductal Adenocarcinoma.
Deng QL; Dong S; Wang L; Zhang CY; Ying HF; Li ZS; Shen XH; Guo YB; Meng ZQ; Yu JM; Chen QW
Sci Rep; 2017 Sep; 7(1):11524. PubMed ID: 28912447
[TBL] [Abstract] [Full Text] [Related]
7. Thyroid cancer: Risk-Stratified Management and Individualized Therapy.
Raue F; Frank-Raue K
Clin Cancer Res; 2016 Oct; 22(20):5012-5021. PubMed ID: 27742787
[TBL] [Abstract] [Full Text] [Related]
8. Management of complex pelvic masses using a multivariate index assay: a decision analysis.
Kim KH; Zsebik GN; Straughn JM; Landen CN
Gynecol Oncol; 2012 Sep; 126(3):364-8. PubMed ID: 22659191
[TBL] [Abstract] [Full Text] [Related]
9. Ovarian tumours: late extramedullary recurrence of acute leukaemia.
Turial S; Karabul N; Gutjahr P; Engel V; Bierschock S; Schier F
Eur J Pediatr Surg; 2009 Jun; 19(3):184-6. PubMed ID: 19212934
[TBL] [Abstract] [Full Text] [Related]
10. Validation of the 6th edition AJCC Pancreatic cancer staging System: report from the National cancer Database.
Bilimoria KY; Bentrem DJ; Ko CY; Ritchey J; Stewart AK; Winchester DP; Talamonti MS
Cancer; 2007 Aug; 110(4):738-44. PubMed ID: 17580363
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancer.
Pleskow DK; Berger HJ; Gyves J; Allen E; McLean A; Podolsky DK
Ann Intern Med; 1989 May; 110(9):704-9. PubMed ID: 2930108
[TBL] [Abstract] [Full Text] [Related]
